Reached strategic co-operation with Aosaikang Pharm Group

Guangzhou office established

Signed upan exclusive license and supply agreement in China with Synthon,Netherlands for one product approved and launched in Europe

CompletedB+ round financing of tens of millions, led by EfungCapital

February: Signed upan exclusive license and supply agreement in China with Dr. Reddy's for one FDA-approved and marketed product, which was the first FDA-approved ANDA

Global co-developmentofaninnovative dosage form product with Med Pharm,UK

Oselavir®(Oseltamivir Phosphate for Suspension) approved for marketingin China

Global co-developmentofaninnovative dosage form product with LTS, Germany

CompletedB round financing of tens of millions,led by EfungCapital, followed by Lianrun Fund and other investors